Industry landscapes
Get Pro
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE BENGALURU EDITION 2026

Bengaluru’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Bengaluru. Find the leaders. Understand the segments. See where the activity is.

Explore in Radar Read the key signals
Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Bengaluru
IN
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
Companies tracked 403Life Sciences ecosystem in Bengaluru Disclosed funding $1.02B124 companies · all recorded rounds Companies hiring 56With open roles at the snapshot Tracked open roles 845 employers posted in the preceding 30 days
MEET THE COMPANIES

Explore Bengaluru’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Explore the full landscape
Life Sciences company highlights in Bengaluru, snapshot 3 September 2026
Company
MedGenomemedgenome.com$264.66M4 roles883$34.52MFYFY2025 filing
Kapivakapiva.in$78.53M6 roles376Financial figure available in RadarView in Radar
SigTuplesigtuple.com$54.75M—95—
Pandorumpandorum.com$51.39M—26—
Bugworks Researchbugworksresearch.com$49.09M—31$2.62MFYFY2025 filing
Stempeuticsstempeutics.com$47.3M—30$1.37MFYFY2025 filing
Immuneelimmuneel.com$39.34M—67—
Strand Life Sciencesus.strandls.com$36.88M—522$12.21MFYFY2025 filing
4baseCare4basecare.com—4 roles25—
Remidioremidio.com—4 roles153$4.8MFYFY2025 filing
Clinisysclinisys.com—3 roles17—
Femacarefemacare.info—2 roles——
Medevplusmedevplus.com—2 roles18—
The Stackthestack.club—2 roles——
Access Pharmaaccesspharma.com———Financial figure available in RadarView in Radar
Bio-genbio-gen.in———Financial figure available in RadarView in Radar
Bionutriz Healthcarebionutriz.com———Financial figure available in RadarView in Radar
Blue Neem Medical Devicesblueneem.com——302$5.72MFYFY2025 filing
Decode Agedecodeage.com——8—
Futura Surgicarefutura.limited——381Financial figure available in RadarView in Radar
Genotypicgenotypic.co.in——87Financial figure available in RadarView in Radar
HRS Navigationhrsnavigation.com——89—
Healeohealeo.in————
Protein Designproteindesign.co.in————
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only

Explore the live startup set in Radar

No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.

Explore classified startups in Radar ↗
THE KEY SIGNALS

Life Sciences industry KPIs in Bengaluru

A few useful ratios bring the size of this ecosystem into perspective.

3 September 2026
Hiring participation13.9%

56 of 403 tracked companies have open roles.

Funding participation37.2%

150 of 403 tracked companies have a recorded round.

Top 3 funding share39.1%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$304.13K

Midpoint of 355 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 39.1% of disclosed capital, while 62.8% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Bengaluru life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Bengaluru life sciences
$0$41.84M$83.68M$125.52M$167.36M2016: $7.75M20162017: $60.63M20172018: $105.2M20182019: $50.07M20192020: $105.85M20202021: $78.83M20212022: $121.47M20222023: $57.34M20232024: $99.14M20242025: $146.81M2025
View the numbers
Annual life sciences funding and company formation in Bengaluru
YearFunding (USD)FoundedRaising
2016$7.75M2721
2017$60.63M2834
2018$105.2M3326
2019$50.07M2328
2020$105.85M2940
2021$78.83M2739
2022$121.47M2432
2023$57.34M2624
2024$99.14M2033
2025$146.81M920
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • MedGenome26.0%
  • Kapiva7.7%
  • SigTuple5.4%
  • Other companies60.9%

Funding by stage

437 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel266 60.9%
Series A–B69 15.8%
Series C+ / PE13 3.0%
Grants, debt & other89 20.4%

Recent recorded rounds

Latest recorded rounds · USD
1 rounds

Swipe or scroll horizontally to browse.

Series B03/2026
Pandorum $429.41K

Backed by We Founder Circle.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.

Expand panel +
₹ crore · standalone

Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.

FY2025 · annual statements grouped by reported fiscal year; exact entity periods remain on preview rows · 211 reporting entities from 259 eligible matches.

Revenue in covered accounts₹3,285.9 crore

Sum of reporting-entity revenue; not Bengaluru market sales.

Net profit / loss₹-270.7 crore

Combined result for the same cohort.

Aggregate net margin-8.2%

Combined net income ÷ combined revenue.

Median company revenue₹1.2 crore

The middle covered reporting entity.

Profitable entities+40.8%

86 of 211 covered entities.

Top-five concentration+42.6%

Share of covered revenue from the five largest entities.

Annual account trend

Reported cohort totals by year; coverage is stated for every period.

Bar height shows revenue. Changes in coverage can affect totals.

Profitability has two perspectives

FY2025 · 211 reporting entities

Open the company accounts

Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.

211 reporting entities
Continue your financial research in Radar

Explore full company accounts and filings.

View financials in Radar ↗
BENGALURU · INDUSTRY COHORTS

How does life sciences compare?

Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.

IndustryCovered / eligibleRevenue totalMedian revenueNet profit / lossAggregate marginProfitable shareOverlap

Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.

Coverage, calculations & financial sources

Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.

The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.

Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Bengaluru companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

23 of these companies (5.7%) publish at least one Android app — 32 apps in all, carrying 1.4M installs between them.

AppInstallsRatingStore category
KapivaKapiva1.3M—Shopping
Lami.Fit Health App | LamiDNALami53.7K—Health & Fitness
CopilotDaracreds Inc18.7K—Productivity
Janitri: for HospitalsJanitri10.4K—Health & Fitness
Janitri: for MothersJanitri9.7K—Health & Fitness
BioMedsVHS LogiTech7.5K—Medical
OncoBuddy: The Cancer Care App4baseCare6.7K—Health & Fitness
VIBRACONNECT By Ayati DevicesAyati Devices6.4K—Medical
AmmrasAmmras6.4K—Business
NEURO TOUCHYostra5.3K—Health & Fitness

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q1–2025Q3).

SegmentAppsInstallsLeading appRelease trend
Nutraceuticals Tech51.3MKapiva 1.3M
Genomics260.4KLami.Fit Health App | LamiDNA 53.7K
Fitness & Wellness Tech255.6KLiveAltlife 1.8K
Healthcare Booking Platforms355.2KMiracle Drinks 1.4K
Life Sciences Tech1237.6KCopilot 18.7K
Healthcare It935.2KJanitri: for Hospitals 10.4K
Disease Self Management421.9KJanitri: for Mothers 9.7K
Iot Applications612.8KBioMeds 7.5K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2022Q4: 12022Q4: 02022Q42023Q1: 12023Q1: 02023Q12023Q2: 22023Q2: 02023Q22023Q3: 22023Q3: 02023Q32024Q3: 22024Q3: 22024Q32024Q4: 22024Q4: 12024Q42025Q1: 12025Q1: 12025Q12025Q2: 22025Q2: 42025Q22025Q3: 12025Q3: 72025Q32025Q4: 12025Q4: 22025Q4

Darker bars are new releases, lighter bars apps updated. 25 of 32 apps carry a release date. The series ends at 2025Q4, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The Bengaluru life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech303
Medical devices115
Healthtech101
Consumer digital92
Enterprise software73
Deep tech73
Biopharmaceuticals39
Nutritional formula36
Saas36
Healthtech saas26
Chronic disease management22
In vitro diagnostics22

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

303companies
15.2%have hiring activity

46 companies hiring · $852.17M disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

E-commerce - product160
Physical commerce147
Subscription131
Fee-for-service78
Commission on transaction13
Advertising7
E-commerce - service7
Sponsorship1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Mergers & acquisitionsvelbiom.com ↗

The acquisition has been executed via a Business Transfer Agreement (BTA), marking Eris Lifesciences’ strategic expansion into the growing probiotics and microbiome-based therapeutics segment.

Funding rounds4basecare.com ↗

In a recent round led by Ashish Kacholia and Lashit Sanghvi, 4baseCare raised Rs 90 crore.

Funding roundspeptris.com ↗

AI-powered drug discovery startup Peptris also secured ₹70 Cr in a Series A round co-led by IAN Alpha Fund and Speciale Invest this month.

Funding roundskapiva.in ↗

Other recent transactions include Kapiva’s $60 million fundraise led by 360 ONE Asset and Vertex Growth in September.

Funding roundsarticulussurgical.com ↗

Articulus Surgical, a medical device company focused on surgical robotics for minimally invasive soft-tissue procedures, has raised a Seed funding round led by Kalaari Capital.

Funding roundspandorum.com ↗

Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with operations in India and the United States, has announced the closing of a US$18 million in Series B financing round, to advance the clinical development of its disease-modifying, tunable, exosome-based therapies, including Kuragenx, while scaling global manufacturing and expanding operations across the U.S., Japan, and the Middle East.

Mergers & acquisitionsrenalyx.com ↗

Mumbai-based Lords Mark India has acquired 85 per cent holding in Bengaluru based Renalyx Health Systems.

Funding roundsmorphlelabs.com ↗

Morphle Labs, a Bengaluru, India-based healthtech startup specializing in robotics and AI for pathology, has raised $5 million in Series A funding led by Inflexor Ventures.

Funding roundshrsnavigation.com ↗

HRS Navigation, a fast-growing Indian medtech company, has raised $5 million in a Pre-Series A funding round backed by GVFL, Physis Capital, Sathguru Catalysers, India EXIM Bank and KITVEN.

Mergers & acquisitionsforushealth.com ↗

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr. B.S. Ajaikumar of HCG, has acquired a 21% stake in Forus Health Private Limited, an Indian ophthalmic diagnostics firm.

Full recorded event mix

Top 10 categories among 118 recorded events in the 24-month window.

Funding rounds
64
Leadership moves
13
Mergers & acquisitions
12
Contracts
10
Capital infusions
5
Fda Approval
2
Fundraising
2
IPO activity
2
Earnings
2
Lawsuit
1
5 activity cards

Swipe or scroll horizontally to browse.

IPO pipeline

1 companies with recorded IPO activity

IPO · NASDAQ2 reports

Leadership moves

1 tracked people moves

Vinod Bhat

Appointment Chief Executive Officer

Regulatory events

2 recorded events

Aurigene ↗

appeal dismissedAppellate Joint Commissioner of State Tax, Hyderabad Rural Division

Aurigene ↗

penalty imposedGST Appellate Authority

Litigation

1 tracked suits

Company
genentech v Protein Design

patent coverage of XolairCivil · Ongoing

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
eris lifesciences→Velbiom Probiotics ↗Completed2026-03-20Not stated in snapshot
Lord’s Mark Industries Ltd.→Renalyx ↗Announced2025-12-03Not stated in snapshot
Lords Mark India→Renalyx ↗Announced2025-11-27Not stated in snapshot
Lord\'S Mark Industries→Renalyx ↗Announced2025-11-26Not stated in snapshot
Inviga Healthcare Fund (IHF)→Forus Health ↗Announced2025-11-04Not stated in snapshot
Clinisys→orchard softwareAnnounced2025-08-14Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

218 postings in the preceding 12 months. The full 251-posting snapshot covers 34 employers.

Expand panel +

Most advertised job titles

Graduate Engineer Trainee9
Graduate Engineering Trainee4
Staff Software Engineer4
Territory Manager3
Senior Data Scientist3
Trainee Engineer3
4 internship postings

0 tracked postings mention remote work.

The seniority mix

153 postings specify a level.

unspecified
98
senior
51
manager
41
entry
29
lead
21
intern
11

Skills employers mention

Top skills across 251 tracked postings in the available jobs snapshot.

Python
23
Sql
13
Project Management
12
Sales
12
Excel
11
Communication Skills
10
Docker
10
Aws
10
Inventory Management
9
Google Sheets
8
THE PEOPLE BUILDING THE FIELD

Founders and leaders

460 founders and chief executives across 307 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

82 profiles with education records.

BITS Pilani
13
Indian Institute of Science
8
IIT Delhi
8
Indian School of Business
6
IIT Kharagpur
6
Stanford University
5
IIT Bombay
5
IIT Kanpur
5

Prior employers

13 profiles with prior-work records.

Amazon
3
Myntra
2
McKinsey
2
Flipkart
2
Microsoft
1
Zoho
1
Cisco
1
Boston Consulting Group
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

2,464 articles in the measured 12-month window.

Expand panel +
2,464articles in the measured year
570articles in 2026Q1
79.4%positive tone in the latest complete year

News volume trends

Life Sciences coverage tagged Bengaluru · articles per complete quarter

02565127681,0252021Q2: 6492021Q22021Q3: 4662021Q4: 3482022Q1: 3222022Q2: 4452022Q22022Q3: 5092022Q4: 5142023Q1: 4732023Q2: 5222023Q22023Q3: 5092023Q4: 5622024Q1: 4702024Q2: 5252024Q22024Q3: 6862024Q4: 7422025Q1: 8912025Q2: 6732025Q22025Q3: 6272025Q4: 6462026Q1: 5702026Q1
View quarterly article counts
QuarterArticles
2021Q2649
2021Q3466
2021Q4348
2022Q1322
2022Q2445
2022Q3509
2022Q4514
2023Q1473
2023Q2522
2023Q3509
2023Q4562
2024Q1470
2024Q2525
2024Q3686
2024Q4742
2025Q1891
2025Q2673
2025Q3627
2025Q4646
2026Q1570

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
1,183 positive · 8 neutral · 356 negative
2022
1,464 positive · 17 neutral · 309 negative
2023
1,703 positive · 17 neutral · 345 negative
2024
2,058 positive · 16 neutral · 348 negative
2025
2,249 positive · 21 neutral · 564 negative

Leading coverage topics

Life Sciences coverage tagged Bengaluru · ranked by full-period article count.

Covid 19 Vaccine Development And Efficacy Trials11,532 articles in the full recorded period
193 recent · 205 prior
Drug Pricing And Reimbursement Strategies7,956 articles in the full recorded period
2,481 recent · 1,790 prior
Vaccine Research And Production Methods7,202 articles in the full recorded period
487 recent · 424 prior
Generic Drug Development And Market Trends6,873 articles in the full recorded period
2,172 recent · 1,461 prior
Covid 19 Vaccination Campaigns And Rollout Strategies5,668 articles in the full recorded period
113 recent · 87 prior
Pharmaceutical Supply Chain Management5,449 articles in the full recorded period
1,927 recent · 1,103 prior
Pharmaceutical Marketing And Sales Strategies3,945 articles in the full recorded period
1,433 recent · 971 prior
Economy News: Central Bank Interest Rate Decisions3,051 articles in the full recorded period
724 recent · 854 prior
Economy News: Inflation Rate Analysis2,998 articles in the full recorded period
641 recent · 815 prior
Pharmaceutical Manufacturing Techniques2,996 articles in the full recorded period
1,180 recent · 522 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

India comparison coverage

KeywordRecentPriorChange
generic drug approval96260758%
drug distribution48833247%
innovator drug patents26717453%
medication patent litigation22814854%
drug safety monitoring22612187%
drug patent exclusivity22615348%
regulatory inspection19912855%
drug repurposing ai18413042%
diagnostic biotechnology1599666%
commodity futures14849202%
core inflation rate454749-39%
inflation analysis329492-33%
headline inflation203316-36%
test cricket66314-79%
stock indices119283-58%

Event and signal lenses

India comparison coverage

All complete annual cohorts shown
Flat

Regulatory Risk

68,217 classified articles

monetary stance shift, core inflation rate, monetary easing

59.0% critical · 35.0% positive
Flat

Funding Momentum

14,019 classified articles

pre-ipo valuation, ipo prospectus, ipo pricing

52.0% critical · 47.4% positive
Rising

Growth

46,494 classified articles

monetary stance shift, core inflation rate, monetary easing

42.0% critical · 44.4% positive

Life Sciences coverage tagged Bengaluru. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

2,919 papers in the recorded india scope.

Expand panel +
2,919papers
53,147worldwide comparison pool
2,919India-affiliated papers

Research orientation

Promising
1,429
Descriptive
564
Breakthrough
373
Problem-identifying
368
Cautionary
86
Comparative
79
Critical
20

Contribution mix

Empirical
1,316
Reviews
1,195
Methods-led
303
Position pieces
94
Theoretical
11

Tone counts: 2,706 positive · 84 neutral · 129 negative.

Common problems researchers identify
388 papers · 13.3% of this field
  • Agriculture68 papers
  • Antibiotic resistance36 papers
  • Food security33 papers
  • Antimicrobial28 papers
  • Human health28 papers
  • Sustainability27 papers
  • Antibiotics18 papers
  • Resistance17 papers

Landmark: Crops that feed the world 6. Past successes and future challenges to the role played by maize in global food security

Cautions
86 papers · 2.9% of this field
  • Agriculture5 papers
  • Antibiotic resistance5 papers
  • Production5 papers
  • Human health5 papers
  • Antimicrobial4 papers
  • Nutraceutical4 papers
  • Health benefits4 papers
  • Trait4 papers

Landmark: Advances in Edible Coatings for Fresh Fruits and Vegetables: A Review

Opportunities
1,802 papers · 61.7% of this field
  • Agriculture154 papers
  • Gene95 papers
  • Crop94 papers
  • Antimicrobial85 papers
  • Sustainability72 papers
  • Phytochemical71 papers
  • Nutraceutical67 papers
  • Yield64 papers

Landmark: Biomedical photoacoustic imaging

Leading institutions

Cancer Institute
6,674
University of Allahabad
6,494
Aligarh Muslim University
6,048
International Centre for Genetic Engineering and Biotechnology
5,416
Birla Institute of Technology, Mesra
5,381
International Crops Research Institute for the Semi-Arid Tropics
5,235

Leading researchers

Archana Panche
4,874
A D Diwan
4,874
Sheela Chandra
4,874
Kanti Bhooshan Pandey
4,444
Syed Ibrahim Rizvi
4,444
J. E. Till
4,062
E. A. McCulloch
4,062
Rajeev K. Varshney
3,392

Highly cited breakthrough-labelled papers

  • Biomedical photoacoustic imaging2,130 citations
  • Engineering circular RNA for potent and stable translation in eukaryotic cells794 citations
  • Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infe734 citations
  • Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity614 citations
  • Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation595 citations

Common problems researchers identify

363 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Food Safety and SecurityCommon problems researchers identify · 01

Food Safety and Security

65 papers

17.9% of this theme group

Researchers highlight risks from contaminants and processing methods affecting nutrition and public health.

Food safety (11) · Population (9) · Food processing (6) · Food security (11)

Aflatoxins: A Global Concern for Food Safety, Human Health and Their Management

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
2022448.5
2023426.3
2024331.6
2025340.6
Medicinal Plant ValidationCommon problems researchers identify · 02

Medicinal Plant Validation

61 papers

16.8% of this theme group

Papers discuss challenges in replicating phytochemical efficacy and standardizing therapeutic use.

Medicinal plants (10) · Drug (9) · Phytochemical (6) · Replication (4)

Significance of Antioxidant Potential of Plants and its Relevance to Therapeutic Applications

Foundations of Phytochemistry: Isolation, Characterization and Bioactive Potential of Medicinal Plants

View research history
YearShare index
2022155.9
2023147.2
2024146.2
2025177.3
Biomass Conversion IssuesCommon problems researchers identify · 03

Biomass Conversion Issues

58 papers

16.0% of this theme group

Studies point to technical hurdles in scaling biofuel and bioprocess technologies.

Biomass (8) · Bioprocess (4) · Biofuel (4) · Synthetic biology (4)

Antimicrobial active packaging with biopolymers and natural extracts: sustainable solutions and technological challenges

Phytochemical profiling and pharmaceutical exploitation of indigenous vegetables: Extraction technologies and therapeutic potential

View research history
YearShare index
202249.5
202348.1
202450.6
202553.3
Crop Trait Improvement LimitsCommon problems researchers identify · 04

Crop Trait Improvement Limits

55 papers

15.2% of this theme group

Authors note constraints in breeding, germplasm access, and trait stability under field conditions.

Crop (11) · Agriculture (17) · Germplasm (5) · Trait (4)

Disease Impact on Wheat Yield Potential and Prospects of Genetic Control

Successes, constraints, and prospects for sustainable dairy cattle breeding using artificial insemination technology in Tanzania. A brief re

View research history
YearShare index
20221637.9
20231669.5
20241798.9
20252019.3
Antimicrobial Resistance ThreatsCommon problems researchers identify · 05

Antimicrobial Resistance Threats

49 papers

13.5% of this theme group

Research emphasizes rising resistance and the need for new control strategies.

Antibiotic resistance (34) · Antibiotics (18) · Antimicrobial (19) · Resistance (9)

Antimicrobial Resistance

Microbiological Innovations as a Defence Against Antimicrobial Resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Sustainable Agriculture ChallengesCommon problems researchers identify · 06

Sustainable Agriculture Challenges

42 papers

11.6% of this theme group

Works identify gaps in applying nanotech and other innovations for long‑term food security.

Agriculture (22) · Food security (16) · Sustainability (12) · Sustainable agriculture (6)

Nanotechnology in Sustainable Agriculture: Recent Developments, Challenges, and Perspectives

Nanoparticle-Based Sustainable Agriculture and Food Science: Recent Advances and Future Outlook

View research history
YearShare index
20221512.8
20231564.0
20241741.7
20251985.7
Abiotic Stress ManagementCommon problems researchers identify · 07

Abiotic Stress Management

33 papers

9.1% of this theme group

Papers explore plant and microbial responses to environmental stresses and their engineering limits.

Abiotic stress (7) · Abiotic component (7) · Rhizosphere (5) · Gut flora (5)

Salicylic acid-induced abiotic stress tolerance and underlying mechanisms in plants

Phytohormones and their metabolic engineering for abiotic stress tolerance in crop plants

View research history
YearShare index
2022102.7
202387.9
202480.5
202578.5

Cautions

80 papers · 4 recurring themes
4 cards

Swipe or scroll horizontally to browse.

Caution on Antimicrobial StrategiesCautions · 01

Caution on Antimicrobial Strategies

29 papers

36.2% of this theme group

Authors warn about limited efficacy and safety concerns of new antimicrobial agents.

Antimicrobial (5) · Antibiotic resistance (5) · Resistance (3) · Antifungal (3)

Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods

Essential Oils as Antimicrobial Agents Against WHO Priority Bacterial Pathogens: A Strategic Review of In Vitro Clinical Efficacy, Innovatio

View research history
YearShare index
2022506.1
2023490.6
2024534.6
2025628.6
Nutraceutical Health ClaimsCautions · 02

Nutraceutical Health Claims

26 papers

32.5% of this theme group

Studies advise careful evaluation of health benefits and shelf‑life impacts of fortified foods.

Nutraceutical (4) · Human health (3) · Health benefits (3) · Shelf life (2)

Advances in Edible Coatings for Fresh Fruits and Vegetables: A Review

Biofortification of horticultural crops for improving human nutrition and health

View research history
YearShare index
2022182.0
2023191.5
2024225.2
2025285.6
Genotoxicity of NanomaterialsCautions · 03

Genotoxicity of Nanomaterials

20 papers

25.0% of this theme group

Research highlights potential DNA damage and oxidative stress from engineered nanoparticles.

DNA damage (4) · Trait (3) · Oxidative stress (2) · Genotype (2)

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies

Mechanisms of genotoxicity. A review of<i>in vitro</i>and<i>in vivo</i>studies with engineered nanoparticles

View research history
YearShare index
2022193.3
2023213.1
2024157.5
2025150.6
Methodological Limits in Food AnalysisCautions · 04

Methodological Limits in Food Analysis

5 papers

6.2% of this theme group

Papers point out gaps in analytical techniques for novel food components.

Analytical Methods for Identification and Quantification of Quinoa Saponins: A Review

Salinity responses and tolerance mechanisms in sugarcane (Saccharum officinarum L.): Recent updates and future perspectives

Opportunities

1,738 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Gene Regulation for Cancer TherapyOpportunities · 01

Gene Regulation for Cancer Therapy

372 papers

21.4% of this theme group

Investigations focus on modulating apoptosis and cytotoxic pathways as therapeutic avenues.

Downregulation and upregulation (26) · Apoptosis (21) · Gene (50) · Cytotoxicity (22)

Apoptotic and Anti-Proliferative Potential of Spirulina platensis Methanolic Extract Against the Human Breast Cancer Cell Line MDA-MB-231: A

Methylation and Expression Analysis of POU4F2, HOXA9, RBM46, and TSGA10 Genes in Bladder Cancer Using Methyl-Sensitive Restriction Enzyme PC

View research history
YearShare index
20222553.7
20232549.4
20242215.8
20251724.1
Microbial BiopesticidesOpportunities · 02

Microbial Biopesticides

254 papers

14.6% of this theme group

Research explores using antagonistic microbes and metabolites to replace chemical pesticides.

Antimicrobial (52) · Fungicide (21) · Antibiotic resistance (26) · Biological pest control (22)

Exploitation of microbial antagonists for the control of postharvest diseases of fruits: a review

Harnessing secondary metabolites of endophytic microbes: a next-generation biopesticide for crop disease management

View research history
YearShare index
2022520.4
2023505.5
2024546.7
2025641.2
Fermented Feed EnhancementsOpportunities · 03

Fermented Feed Enhancements

252 papers

14.5% of this theme group

Studies assess fermented ingredients to improve nutrient utilization and growth performance in livestock.

Feed conversion ratio (22) · Broiler (17) · Nutrient (31) · Fermentation (27)

Effect of Dietary Supplementation of Mushroom (Agaricus bisporus) Fruiting Body Waste Powder on Growth Performance, Nutrient Utilization and

Millet Fermentation: Biochemical Transformations, Health Impacts, and Enhanced Nutritional Profiles

View research history
YearShare index
2022128.2
2023121.4
2024117.2
2025127.6
Genomics‑Driven Crop ResilienceOpportunities · 04

Genomics‑Driven Crop Resilience

232 papers

13.3% of this theme group

Works propose integrated breeding and sequencing to boost drought tolerance and yield stability.

Agriculture (75) · Crop (45) · Abiotic stress (26) · Food security (28)

Integrated genomics, physiology and breeding approaches for improving drought tolerance in crops

Harvesting the Promising Fruits of Genomics: Applying Genome Sequencing Technologies to Crop Breeding

View research history
YearShare index
20221662.6
20231685.0
20241813.1
20252032.4
Sustainable Biomass UtilizationOpportunities · 05

Sustainable Biomass Utilization

223 papers

12.8% of this theme group

Papers highlight converting agri‑food waste into biofuels and high‑value bioproducts.

Sustainability (45) · Production (24) · Biomass (18) · Biofuel (14)

Advances in green synthesis of nanoparticles for biomedical applications: Antimicrobial, antiviral, and cancer therapies

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
2022227.8
2023251.9
2024312.0
2025440.0
Genetic Diversity for Yield GainsOpportunities · 06

Genetic Diversity for Yield Gains

222 papers

12.8% of this theme group

Research emphasizes exploiting germplasm variation to accelerate breeding for higher productivity.

Heritability (37) · Germplasm (45) · Genetic diversity (32) · Yield (41)

Assessment of Genetic Variability for Yield-Related Traits in Lentil (Lens culinaris Medik.) Germplasms

Genetic Variability and Heritability of Maize Yield in Diverse Inbred Lines: Implications for Economically Efficient Breeding

View research history
YearShare index
202265.4
202358.4
202452.0
202560.4
Phytochemicals for Health ProductsOpportunities · 07

Phytochemicals for Health Products

183 papers

10.5% of this theme group

Studies investigate medicinal plants and nutraceuticals as sources of functional food ingredients.

Phytochemical (43) · Medicinal plants (31) · Nutraceutical (33) · Health benefits (32)

Phytochemistry, pharmacology, and traditional uses of beverage plants with dietary hormetic potential for human health

Leveraging Medicinal Herbs and Fruits for Functional Dairy: A Review of Phytochemistry, Technology, and Health Outcomes

View research history
YearShare index
202269.0
202363.8
202460.3
202587.9

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Promising49.0%37.0%
Descriptive19.3%17.3%
Breakthrough12.8%26.4%
Problem-identifying12.6%9.8%
Cautionary2.9%4.4%
Comparative2.7%4.1%
Critical0.7%0.9%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Hardware, e-waste & supply chainFruit and Vegetable Waste: Bioactive Compounds, Their Extraction, and Possible Utilization50.18%0 (0.0%)0.15%
Privacy & surveillanceArtificial intelligence and internet of things enabled systems for smart veterinary disease detection30.11%1 (33.3%)0.21%
Energy & datacenter footprint00.0%0 (%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Safety & misuse00.0%0 (%)0.01%
Bias & fairness00.0%0 (%)0.03%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: India. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Bengaluru

Published patent filings in the recorded source window.

Expand panel +
502filings 2016–2025
28assignees
61peak annual filings

Filing momentum

0183553702016: 5920162017: 592018: 5620182019: 582020: 4420202021: 612022: 5020222023: 422024: 4320242025: 302025

Who files the most

Biocon
689
Avesthagen
87
String Bio
42
Anthem Biosciences
25
National Centre For Biological Scien
19
Sami-sabinsa Group
13
Gangagen
13
Namdhari Seeds
9
DEMAND, SUPPLY & PLACE

Where demand signals run ahead of mapped supply — Bengaluru

Compare demand signals in Bengaluru’s newsflow with the life sciences categories mapped to each signal.

Expand panel +
HOW TO READ THE GAP

Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.

The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.

COMPARISON PERIOD2025-05-01 to 2026-05-01Against 2024-05-01 to 2025-05-01Explore the signals ↓

The opportunity, in one view

Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.

Swipe horizontally to compare all columns →

5 Bengaluru demand signals compared with mapped life sciences supply
Signal familySignal percentileSupply percentileRelative gapGap (points)Signal share vs prior year
Infectious outbreaks ↗Disease Burden29.20.0+29.2-13.0%
Layoffs & income shocks ↗Spending Pressure87.566.7+20.8+29.7%
Maternal & child health ↗Disease Burden25.033.3-8.3—
Air pollution ↗Environmental Driver25.0100.0-75.0-52.2%
Mental health ↗Disease Burden83.3—No matching category—+6.0%

Showing all 5 signals. Select a family for its history and mapped categories.

Where the signals are loudest

All 12 city readings for these demand families in the comparison geography. Bengaluru is highlighted.

Mentions per 10,000 articles

Each city’s reading is a share of its own coverage. Rows cover all of India for this page's signal families; Bengaluru is marked.

Ghaziabad495.3

Air pollution · Mental health · Maternal & child health

Delhi319.9

Air pollution · Mental health · Infectious outbreaks

Faridabad274.0

Air pollution · Mental health · Maternal & child health

Kanpur241.1

Mental health · Maternal & child health · Air pollution

Noida221.3

Air pollution · Mental health · Layoffs & income shocks

Thiruvananthapuram158.4

Mental health · Infectious outbreaks · Maternal & child health

Dehradun151.5

Mental health · Air pollution · Infectious outbreaks

Nagpur140.2

Mental health · Maternal & child health · Infectious outbreaks

Gorakhpur137.7

Mental health · Maternal & child health · Infectious outbreaks

BengaluruThis page123.0

Mental health · Layoffs & income shocks · Air pollution

Udaipur137.7

Mental health · Maternal & child health · Infectious outbreaks

Patna130.2

Mental health · Maternal & child health · Air pollution

Inside the leading signals

Open any signal for its quarterly history
DISEASE BURDENInfectious outbreaks+29.2percentile-point gap
THE OPERATING HYPOTHESIS

Outbreak pressure can pull testing, surveillance and rapid-care demand at short notice.

13.94mentions per 10,000 articles-13.0%share change vs prior year

Mapped life sciences categories

  • In Vitro Diagnostics22

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of Bengaluru coverage

Mentions per 10,000 articles · zero baseline

091828372024Q3: 132024Q32024Q4: 72024Q42025Q1: 312025Q12025Q2: 272025Q22025Q3: 152025Q32025Q4: 112025Q42026Q1: 62026Q1
View quarterly signal counts
Infectious outbreaks in Bengaluru coverage
QuarterMentionsPer 10,000 articles
2024Q31713.31
2024Q4117.61
2025Q14731.91
2025Q23627.32
2025Q32215.88
2025Q41611.85
2026Q1126.35

Where this signal concentrates in the comparison geography

Thiruvananthapuram39.2 / 10,000
Prayagraj34.5 / 10,000
Nagpur32.0 / 10,000
SPENDING PRESSURELayoffs & income shocks+20.8percentile-point gap
THE OPERATING HYPOTHESIS

Layoff cycles can pull discretionary spend back toward value offerings.

30.7mentions per 10,000 articles+29.7%share change vs prior year

Mapped life sciences categories

  • Biopharmaceuticals39

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of Bengaluru coverage

Mentions per 10,000 articles · zero baseline

091827372024Q3: 202024Q32024Q4: 172024Q42025Q1: 212025Q12025Q2: 272025Q22025Q3: 312025Q32025Q4: 312025Q42026Q1: 252026Q1
View quarterly signal counts
Layoffs & income shocks in Bengaluru coverage
QuarterMentionsPer 10,000 articles
2024Q32620.36
2024Q42617.98
2025Q13221.73
2025Q23627.32
2025Q34431.76
2025Q44231.12
2026Q14925.95

Where this signal concentrates in the comparison geography

Noida39.6 / 10,000
Bengaluru30.7 / 10,000
DISEASE BURDENMaternal & child health-8.3percentile-point gap
THE OPERATING HYPOTHESIS

Maternal and child burden can pull immunisation, nutrition and pediatric care demand.

10.46mentions per 10,000 articles

Mapped life sciences categories

  • Nutritional Formula36

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of Bengaluru coverage

Mentions per 10,000 articles · zero baseline

04812162024Q3: 32024Q32024Q4: 112024Q42025Q1: 32025Q12025Q2: 72025Q22025Q3: 72025Q32025Q4: 142025Q42026Q1: 72026Q1
View quarterly signal counts
Maternal & child health in Bengaluru coverage
QuarterMentionsPer 10,000 articles
2024Q343.13
2024Q41711.76
2025Q153.4
2025Q2107.59
2025Q3117.94
2025Q41914.08
2026Q1147.41

Where this signal concentrates in the comparison geography

Kanpur60.3 / 10,000
Patna42.0 / 10,000
Nagpur41.8 / 10,000
ENVIRONMENTAL DRIVERAir pollution-75.0percentile-point gap
THE OPERATING HYPOTHESIS

Sustained air-quality stress can pull respiratory and cardiac care demand with it.

15.93mentions per 10,000 articles-52.2%share change vs prior year

Mapped life sciences categories

  • Chronic Disease Management22
  • In Vitro Diagnostics22

Companies can appear in multiple categories; these counts are not a unique-company total.

Quarterly share of Bengaluru coverage

Mentions per 10,000 articles · zero baseline

0132538512024Q3: 292024Q32024Q4: 342024Q42025Q1: 442025Q12025Q2: 72025Q22025Q3: 142025Q32025Q4: 282025Q42026Q1: 112026Q1
View quarterly signal counts
Air pollution in Bengaluru coverage
QuarterMentionsPer 10,000 articles
2024Q33829.75
2024Q45034.58
2025Q16544.14
2025Q2107.59
2025Q32014.43
2025Q43928.9
2026Q12211.65

Where this signal concentrates in the comparison geography

Ghaziabad355.9 / 10,000
Delhi269.3 / 10,000
Faridabad130.7 / 10,000
DISEASE BURDENMental health—supply not mapped
THE OPERATING HYPOTHESIS

Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.

51.95mentions per 10,000 articles+6.0%share change vs prior year

Mapped life sciences categories

This signal has no matching category in the page’s life sciences market map, so no supply percentile or gap is assigned.

Quarterly share of Bengaluru coverage

Mentions per 10,000 articles · zero baseline

0244872962024Q3: 232024Q32024Q4: 832024Q42025Q1: 502025Q12025Q2: 452025Q22025Q3: 392025Q32025Q4: 622025Q42026Q1: 562026Q1
View quarterly signal counts
Mental health in Bengaluru coverage
QuarterMentionsPer 10,000 articles
2024Q33023.49
2024Q412183.68
2025Q17450.25
2025Q26045.54
2025Q35539.69
2025Q48462.24
2026Q110756.66

Where this signal concentrates in the comparison geography

Kanpur119.0 / 10,000
Ghaziabad96.6 / 10,000
Thiruvananthapuram89.4 / 10,000
RESEARCH & CHANGING CONVERSATIONS

Related research and changing coverage

Bengaluru life sciences coverage

Expand panel +
RESEARCH CONTEXT · 2019

Prenatal Depression and Its Associated Risk Factors Among Pregnant Women in Bangalore: A Hospital Based Prevalence Study

Frontiers in Public Health

129 citations in the snapshot

RESEARCH CONTEXT · 2020

Do Low Self-Esteem and High Stress Lead to Burnout Among Health-Care Workers? Evidence From a Tertiary Hospital in Bangalore, India

Safety and Health at Work

61 citations in the snapshot

RESEARCH CONTEXT · 2019

Prevalence and risk factors of anemia among pregnant women attending a public-sector hospital in Bangalore, South India

Journal of Family Medicine and Primary Care

46 citations in the snapshot

RESEARCH CONTEXT · 2019

Oral health knowledge, attitude and practices among nurses in a tertiary care hospital in Bangalore, India: a cross-sectional survey

Contemporary Nurse

38 citations in the snapshot

What is growing in this coverage

Bengaluru coverage of this page's demand families

KeywordRecent articlesPrior articlesShare change
air quality standards21186.3%
pollution monitoring2422-0.6%
online harassment suicides1616-8.9%

Share changes describe coverage in the stated comparison periods, not search demand or market size.

UNDERSTAND THE LANDSCAPE

Life Sciences in Bengaluru: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

KEEP EXPLORING

Put Bengaluru in context

All landscapes ↗

Company ecosystem snapshot: 3 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon